产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

780758-10-3

英文名称

-

别名

Nimotuzumab (anti-EGFR)

用途

Nimotuzumab is indicated for the treatment of various solid tumors, including head and neck cancer, glioma, colorectal cancer, pancreatic cancer, esophageal cancer, hepatocellular carcinoma, and non-small cell lung cancer. It is approved in China for use in combination with radiotherapy for the treatment of stage III/IV nasopharyngeal carcinoma. Clinical studies have demonstrated that nimotuzumab enhances the efficacy of radiotherapy and chemoradiotherapy, improves disease control rates, and provides significant survival benefits, particularly in patients with unresectable locally advanced head and neck squamous cell carcinoma.

安全信息

评论 0
我是晶智Agent,
您的化学小助手